Glythera Limited

PERMACARB

Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, data packages, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; Printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine;PERMA CARB;Chemicals used in industry and science; chemical products for use in industry and science namely, difluorosialic acid; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents; chemical preparations for scientific and industrial processes, namely, difluorosialic acid; enzymes for scientific and industrial purposes; biological cell cultures for use in scientific research;Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, production and analysis of glycoproteins, and scientific analysis of antibody-drug conjugates and biotherapeutics; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines, biotherapeutics and antibody-drug conjugates; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; information, advisory and consultancy services relating to the aforesaid;